|
Inhibidores de la neuraminidasa para la profilaxis y tratamiento de la nueva influenza A H1N1.9
- Centers for Disease Control and Prevention (CDC). Directrices provisionales para el control de infecciones y recomendaciones para el uso de medicamentos antivirales en pacientes con infección presunta o confirmada por influenza porcina (gripe porcina) tipo A (H1N1) y en personas que hayan tenido contacto cercano con ellos. http://www .cdc. gov/ swine flu/ espanol /recomendaciones (accesado Abril ,2009)
- Centers for Disease Control and Prevention (CDC). Interim Guidance for Clinicians on the Prevention and Treatment of swine-origin Influenza Virus Infection in Young Children. http://www. cdc. gov/ swine flu/ children treatment (accesado Abril, 2009)
- Centers for Disease Control and Prevention (CDC). Interim guidance on antiviral recommendations for patients with novel influenza A (H1N1) virus infection and their close contacts. Atlanta (GA): The Centers 2009; www. cdc. gov/ h1n1 flu/ recommendations.htm (accesado Mayo, 2009)
- Centers for Disease Control and Prevention (CDC). Novel H1N1 flu (swine flu) and feeding your baby: what parents should know. Atlanta (GA): The Centers 2009; www. cdc. gov/ h1n1 flu/ breast feeding. htm (accesado Mayo, 2009)
- Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2007; 56:1-60
- Centers for Disease Control and Prevention (CDC). Three Reports of Oseltamivir Resistant Novel Influenza A (H1N1) Viruses. http://www. cdc. gov/ h1n1 flu/ HAN/ 070909. htm (accesado Julio, 2009)
- Committee on Infectious Diseases. Antiviral therapy and prophylaxis for influenza in children. Pediatrics 2007; 119:852-860
- Chowell G, Bertozzi S, Colchero M, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, Miller M. Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza. The New England Journal of Medicine 2009; 361:1-6
- Democratis J, Pareek M, Stephenson I. Use of neuraminidase inhibitors to combat pandemic influenza. Journal of Antimicrobial Chemotherapy 2006; 58:911-915
- Fica A. Influenza: Una revision de su quimioprofilaxis y terapéutica antiviral. Rev Chil Infect 2001; 18(2):127-131
- Fouchier R, Munster V, Wallensten A, Bestebroer T, Herfst S, Smith D, Rimmelzwaan G, Olsen B, Osterhaus A. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005; 79:2814-2822
- Freund B, Gravenstein S, Elliott M, et al. Zanamivir: a review of clinical safety. Drug Saf 1999; 21:267-281
- Girón B, Cáceres B. Influenza: La pandemia del siglo XXI. Revista del Instituto Nacional de Higiene Rafael Rangel 2004; 35(2)
- Gorman O, Bean W, Kawaoka Y, Webster R. Evolution of the nucleoprotein gene of influenza A virus. J Virol 1990; 64:1487-1497
- Guía clínica para el manejo de casos Nueva Influenza Humana A (H1N1) Etapa de Mitigación. Gobierno de Chile Ministerio de Salud, 29-05-2009. pp. 1-9
- Hayashi M, Yamane R, Tanaka M, et al. Pregnancy outcome after maternal exposure to oseltamivir phosphate during the first trimester: a case series survey [Japanese]. Nihon Byoin Yakuzaishi Gakkai Zasshi 2009; 45:547-550
- Hayden F, Atmar R, Schilling M, Johnson C, Poretz D et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999; 341:1336-1343
- Hayden F, Treanor J, Fritz R, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza. JAMA 1999; 282:1240-1246
- Hayden F. Antiviral resistance in influenza viruses-implications for management and pandemic response. New Engl J Med 2006; 354:785-788
- He G, Massarella J, Aitken M, et al. The pharmacokinetics and safety of the oral neuraminidase inhibitor Ro 64-0796/GS4104 when administered concurrently with cimetidine or probenecid in healthy subjects. J Antimicrob Chemother 1999; 44(Suppl A):44
- Heinen P. Swine influenza: a zoonosis. Veterinary Sciences 2003. http://www. Vet scite.org/ ublish /articles /000041 /print.html (accesado Abril, 2009)
- Heymann D. –ed. Influenza. En: El Control de las enfermedades transmisibles. 18a ed. Washington, D.C.: OPS, 2005. Publicación Científica y Técnica No. 613
- Hope-Simpson R. The role of season in the epidemiology of influenza. J Hyg 1981; 86:35-47
- Horimoto T, Rivera E, Pearson J, Senne D, Krauss S, Kawaoka Y, et al. Origin an molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. Virology 1995; 213:223-230
- Imaz M, Eimann M, Poyard E, Savy V. Exceso de mortalidad asociada a influenza en Argentina 1992-2002. Revista Chilena de Infectología 2006; 23(4):297-306
- Institute of Medicine (IOM).Pandemic Influenza A Guide to Recent Institute of Medicine Studies and Workshops. May, 2009. pp. 1-5
- Jefferson T, Demicheli V, Di Pietrantonj C, Jones M, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database of Systematic Reviews 2006; (3):CD001265
- Jefferson T, Foxlee R, Del Mar C et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2008; 336:77-80
- Jofré L. Tratamiento y profilaxis de influenza estacional en niños. Neumología Pediátrica 2009; 4(1):29-34
- Kandun I, Tresnaningsih E, Purba W, Lee V, Samaan G et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. The Lancet 2008; 372:744-749
- Lessler J, Reich N, Brookmeyer R, Perl T, Nelson K, Cummings D. Incubation periods of acute respiratory viral infections: a systematic review. The Lancet Infectious Diseases 2009; 9:291-300
- Longini I, Halloran E, Nizam A, Yang Y. Containing Pandemic Influenza with Antiviral Agents. American Journal of Epidemiology 2004; 159(7): 623-633
- Massarella J, Ward P. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite RO 64-0802. Clin Pharmacokinet 1999; 37:471-484
- Matheson N, Symmonds-Abrahams M, Sheik A, Shepperd S, Harnden A. Neuraminidase inhibitors and treating influenza in children. Cochrane Databse System Rev 2003; 3.CD002747
- Matrosovich M, Matrosovich T, Gray T, Roberts N, Klenk H. Neuraminidase Is Important for the Initiation of Influenza Virus Infection in Human Airway Epithelium. Journal of Virology 2004; 78(22):12665-12667
- McKimm-Breschkin J. Resistance of influenza virus to neuraminidase inhibitors: a review. Antiviral Res 2000; 47:1-17
- Miller M, Viboud C, Olson D, Grais R, Rabaa M, Simonsen L. Prioritization of Influenza Pandemic Vaccination to Minimize Years of Life Lost. The Journal of Infectious Diseases 2008; 198:305-311
- Monto A, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical Signs and Symptoms Predicting Influenza Infection. Arch Intern Med 2000; 160:3243-3247
- Monto A, Robinson D, Herlocher M, Hinson J, Elliot M, Crisp A. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA 1999; 282:31-35
- Monto A. The role of antivirals in the control of influenza. Vaccine 2003; 21:1796-1800
- Morens D, Taubenberger J, Fauci A. The Persistent Legacy of the 1918 Influenza Virus. The New England Journal of Medicine 2009; 361(3):225-229
- Moretti M, Bar-Oz B, Fried S, et al. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 2005; 16:216-219
|